Fierce Pharma

DECEMBER 9, 2022

ASH: Bristol Myers bolsters Breyanzi's case in earlier lymphoma amid clash with Gilead. aliu. Fri, 12/09/2022 - 09:15.

323

323

Medgadget

DECEMBER 7, 2022

At the University of South Australia, researchers designed a system that allows them to measure a patient’s blood pressure with a camera. The camera visualizes the patient’s forehead and focuses on two regions in particular to optically determine photoplethysmographic signals that AI algorithms then convert to blood pressure data. The researchers tested their system in 25 volunteers, and so far it has proven to be approximately 90% as accurate as traditional pressure cuff measurements.

Management 144

Management Safety Patients Healthcare 144

MedCity News

DECEMBER 9, 2022

Women’s health has been historically underfunded — in terms of both research dollars and venture capital investment. Lawmakers can’t craft effective policy nor can startups innovate in the women’s health space without good data and research, said panelists at a recent healthcare conference in Washington, D.C.

Healthcare 134

Healthcare Healthcare 134

pharmaphorum

DECEMBER 7, 2022

Elon Musk’s brain computer interface (BCI) company Neuralink is being investigated by law enforcement authorities in the US amid allegations of animal welfare violations in its testing facilities. Neuralink’s BCI is intended to treat conditions like blindness and spinal cord injury, as well as provide a way to interact with digital devices using the brain and, according to Musk, is on the brink of moving into the human testing stage.

Side effects 122

Side effects Media Physicians Medical 122

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

DECEMBER 9, 2022

Senator presses Amgen with 'final request' for information in tax probe. kdunleavy. Fri, 12/09/2022 - 09:50.

298

298

Pharmaceutical Technology

DECEMBER 8, 2022

Kite Pharma and Daiichi Sankyo have updated a partnership agreement signed in 2017 for the former’s CAR T-cell therapy, Yescarta (axicabtagene ciloleucel). Under the prior deal, Daiichi Sankyo acquired exclusive rights for the development, manufacturing and commercialisation of Yescarta in Japan. Subsequently, in the same year, Gilead Sciences acquired Kite.

Manufacturing 122

Manufacturing Marketing Patients Engineering 122

pharmaphorum

DECEMBER 5, 2022

A digital health assistant that can help people at risk of becoming dependent on alcohol has been launched in Belize, its first country, by the World Health Organisation (WHO) and Pan-American Health Organisation (PAHO). The artificial intelligence-powered assistant – called Pahola and available as a free online chat-based site – is designed to provide information and guidance to help people reduce their alcohol consumption, helping to prevent more than 200 health conditions linked to excessive

Leads 122

Leads Marketing Patients 122

Fierce Pharma

DECEMBER 9, 2022

AZ writes the 'next chapter' in Enhertu's saga with head-to-head win versus Roche's Kadcyla. fkansteiner. Fri, 12/09/2022 - 09:22.

290

290

PharmExec

DECEMBER 8, 2022

Our annual report spotlighting notable investments in new drug development captures a mix of gradual gains and giant leaps—both equally as promising—in five expanding and diverse therapeutic areas: spinal muscular atrophy, hemophilia A, intranasal and inhaled vaccines, gene-targeted therapy, and RNA therapeutics.

119

119

MedCity News

DECEMBER 6, 2022

A hospital corporation with facilities across Massachusetts must pay $1.9 million in civil penalties in a lawsuit alleging that an employee stole more than 17,000 units of controlled substances and the hospitals did not have accurate records of controlled substances to prevent such illegal activity. .

Biopharma 124

Biopharma 124

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

pharmaphorum

DECEMBER 4, 2022

Clinical trials of a wireless brain chip developed by Elon Muck’s Neuralink company will be tested in human volunteers within the next six months – and Musk himself says he intends to have one implanted for a future demo event. Neuralink has been promising that the technology will be ready for clinical trials soon for some time – first saying they were around the corner back in 2019 – so the latest announcement by Musk at an update last week may be met with some scepticism.

Side effects 118

Side effects Recruitment Physicians Food 118

Fierce Pharma

DECEMBER 9, 2022

ASH: Despite partial clinical hold, bluebird's sickle cell gene therapy remains on track. kdunleavy. Fri, 12/09/2022 - 19:15.

278

278

European Pharmaceutical Review

DECEMBER 8, 2022

Geron’s CEO Chip Scarlett spoke to EPR to explain the science behind Imetelstat, the company’s leading telomerase inhibitor candidate. If successful, imetelstat could become the first-ever cancer treatment based on the inhibition of telomerase, helping to treat lower-risk myelodysplastic syndromes (LR MDS) , which leaves many patients dependent on blood transfusions.

Manufacturing 116

Manufacturing Patients Medicine Pharmaceutical 116

MedCity News

DECEMBER 6, 2022

Taking the opposite approach of targeted protein degradation, biotech company Entact Bio is developing medicines that stabilize proteins and even enhances their function. This approach that could apply to cancer and certain rare diseases and Entact’s $81 million in Series A financing enables it to work on multiple programs in parallel.

Medicine 124

Medicine Biopharma Pharma 124

Advertisement

PharmExec

DECEMBER 8, 2022

Companies should search within to gain talent edge.

Pharma 116

Pharma 116

Fierce Pharma

DECEMBER 5, 2022

AstraZeneca partner FibroGen slaps former employees with trade secret theft lawsuit. zbecker. Mon, 12/05/2022 - 10:31.

279

279

Healthcare Success

DECEMBER 6, 2022

Healthcare consumers continue to move swiftly down the paths of least resistance toward quality care. This spells trouble for healthcare organizations that cannot change with the times. It’s time to pay attention to what competitors offer and find ways to remove unnecessary obstacles to care. In this blog, I share nine healthcare marketing trends you need to embrace in 2023 to remain competitive in today’s ever-changing healthcare marketplace. 9 Healthcare Marketing Trends 2023. 1.

Healthcare 113

Healthcare Healthcare Marketing Competition 113

MedCity News

DECEMBER 7, 2022

Hospital and health system revenue cycles will face a labor shortage and external economic pressures for the indefinite future. Automation can help streamline and optimize healthcare revenue cycles, but organizations must use this enabling technology with strategic intent.

Healthcare 122

Healthcare Healthcare Management 122

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

PharmaTimes

DECEMBER 7, 2022

Data reinforces potential to deliver new standards across HER2-targetable breast cancer

111

111

Fierce Pharma

DECEMBER 8, 2022

Takeda's dengue shot scores crucial EU nod, opening the door to wider global use. zbecker. Thu, 12/08/2022 - 11:16.

264

264

pharmaphorum

DECEMBER 8, 2022

Ramesh “Sunny” Balwani, the former business partner of Theranos founder Elizabeth Holmes, has been sentenced to nearly 13 years in prison after being convicted of wire fraud. His sentencing comes after ex-Theranos chief executive Holmes was given more than 11 years in prison last month after also being found guilty of defrauding investors in Theranos, which said it had developed technology that could diagnose a host of diseases with just a few drops of blood taken with a finger prick, rather tha

Doctors 111

Doctors Media Patients Safety 111

MedCity News

DECEMBER 7, 2022

The six-month pilot program aims to support 1,000 Highmark insurance members with certain chronic health conditions and who are at high-risk of food insecurity. These members will receive two medically-tailored meals a day, as well as coaching and social work to help them live a healthier lifestyle.

Medical 122

Medical Food Insurance 122

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

PharmaTimes

DECEMBER 8, 2022

Implantable ARC therapy demonstrates potential to improve blood pressure regulation

106

106

Fierce Pharma

DECEMBER 7, 2022

Troubled Endo shelves cellulite treatment Qwo, lays off 90 employees. kdunleavy. Wed, 12/07/2022 - 09:47.

264

264

European Pharmaceutical Review

DECEMBER 8, 2022

Phase II trial results from the largest global head-to-head trial of programmed death receptor (PD-1) inhibitors in patients with metastatic non-squamous non-small cell lung cancer ( NSCLC ), showed a median progression-free survival (mPFS) of 8.8 months for patients treated with Jemperli (dostarlimab) plus chemotherapy versus 6.7 months for those given pembrolizumab and chemotherapy.

Patients 105

Patients Safety Medical Pharmaceutical 105

MedCity News

DECEMBER 9, 2022

The annual open enrollment period is the right time to proactively address common benefits knowledge roadblocks with more in-depth education and communications.

Healthcare 122

Healthcare Healthcare Education 122

Advertiser: ZoomInfo

Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr

Competition

PharmExec

DECEMBER 8, 2022

Kimberly Moran, head of rare diseases in the US for UCB, started off working in medicine but quickly learned the importance of the business side of industry—and its role in helping improve the diagnosis and access paths for underserved patient segments.

Medicine 105

Medicine Patients 105

Fierce Pharma

DECEMBER 7, 2022

GSK, Sanofi, Pfizer and Boehringer Ingelheim free from federal Zantac litigation with new ruling. zbecker. Wed, 12/07/2022 - 10:05.

264

264

pharmaphorum

DECEMBER 6, 2022

A model framework for generating the evidence to demonstrate the efficacy of digital therapeutics so they can secure regulatory approval and reimbursement has been published by a trade organisation representing digital health companies. The non-profit Digital Therapeutics Alliance (DTA) – working with clinical trials specialist Curebase – has drawn up the document to help encourage the development of DTx products and get them accepted in clinical practice.

Healthcare 105

Healthcare Healthcare Safety Patients 105

MedCity News

DECEMBER 9, 2022

Enthea, a benefit plan administrator, works with self-insured employers to provide insurance coverage for psychedelic-assisted therapy. The company has gained $2 million in seed funding, led by Tabula Rasa Ventures. With the money, it is planning a nationwide rollout.

Insurance 119

Insurance Biopharma 119

Advertisement

Distribution